Cite
APA Citation
Oliva-Damaso, N., & Bomback, A. S. (2021). rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO. Kidney360, 2(11), 1696–1698. http://access.bl.uk/ark:/81055/vdc_100183600998.0x000005
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Oliva-Damaso, N., & Bomback, A. S. (2021). rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO. Kidney360, 2(11), 1696–1698. http://access.bl.uk/ark:/81055/vdc_100183600998.0x000005